Introduction
Leber's hereditary optic neuropathy (LHON) is a maternally pathogenic role has been established for the so-called primary point mutations, which are found in the majority of LHON inherited disease characterized by acute or subacute visual loss, with variable recovery, and associated with the pedigrees (Harding et al., 1995; Riordan-Eva et al., 1995) and affect one of the three nucleotide positions 11 778 degeneration of the retinal ganglion cell layer and optic nerve. It most commonly affects young adult males and is (Wallace et al., 1988), 14 484 (Mackey and Howell, 1992; Johns et al., 1993) and 3460 (Howell et al., 1991 ; Huoponen associated with a number of point mutations of mtDNA (mitochondrial DNA) (Riordan-Eva and Harding, 1995) . A et al., 1991) in genes coding for the ND4, ND6 and ND1 subunits of complex I of the mitochondrial respiratory chain, the identification of heteroplasmic individuals, had a high penetrance (seven affected and six unaffected). Both of these respectively. In contrast, the pathogenic role of other, socalled secondary, point mutations (Johns and Berman, 1991;  families with the 11778/ND4 mutation took part in the haplotype and phylogenetic study of LHON families in Italy Brown et al., 1992a) , occurring in LHON patients only in association with 'primary' mutations, is still controversial (Torroni et al., 1997) : Family 1 was found to carry the haplogroup U and Family 2 was classified as haplogroup K. (Chalmers and Schapira, 1999) . Three of these mutations, at base pairs 4216/ND1, 4917/ND2 and 13708/ND5, all of We also studied 10 subjects from a third family (three males, age 36 Ϯ 11 years, one affected male) carrying the 11778/ which affect complex I subunits, occur in control populations in specific combinations defining the European-specific ND4 plus the two 'secondary' 4216/ND1 and 13708/ND5 mtDNA mutations. This family (Family 3) had five affected haplogroups T (4216/ND1, 4917/ND2) and J (4216/ND1, 13708/ND5) (Brown et al., 1992b; Torroni et al., 1997) . The subjects (four males and one female) and 11 maternally related, unaffected individuals in the last three generations recent finding that in 11778-and 14484-positive LHON patients the frequency of haplogroup J, but not of haplogroup (Vergani et al., 1995) . All the affected individuals were in the high-penetrance, older generation (five affected and two T, is much higher than in controls suggested that the 4216/ ND1 and 13708/ND5 combination may play a role in the unaffected). Unfortunately, we were able to study only one clinically affected member of this pedigree by 31 P-MRS expression of these two 'primary' LHON mutations (Torroni et al., 1997) .
because the other patients had magnetic clips in their brains after surgery for opticochiasmatic arachnoiditis at the time A deficit of brain and skeletal muscle mitochondrial respiration was shown in LHON patients and asymptomatic of their visual loss. All the subjects from this pedigree were found to be homoplasmic and to carry the haplogroup J subjects carrying the 11778/ND4 mutation by in vivo phosphorus magnetic resonance spectroscopy ( 31 P-MRS) (Torroni et al., 1997) . All 20 subjects (patients and unaffected individuals) Barbiroli et al., 1995) . This technique is sensitive enough to detect differences in the extent of the investigated in this study were selected because they were homoplasmic mutant in both leucocytes and platelets and deficit in mitochondrial respiration among subjects, either symptomatic or asymptomatic, carrying one of the three were negative for the other LHON mutations that have been described (3460/ND1, 14484/ND6, 4160/ND1, 5244/ND2, 'primary' LHON mtDNA mutations or with a different mutation load . The aim of the present 7444/COI, 3394/ND1, 4917/ND2, 15257/Cytb, 15812/Cytb). Clinically, the six affected patients investigated in this study study was to establish whether the presence of the 'secondary' LHON mtDNA mutations 4216/ND1 and 13708/ND5 further showed similar reduced visual acuity as a consequence of acute or subacute visual loss. The age at onset was 24-impairs mitochondrial oxidative metabolism in subjects with the 11778/ND4 mtDNA mutation. We assessed brain and 41 years for the five patients carrying only the 11778/ND4 mtDNA mutation and 33 years for the one patient who skeletal muscle energy metabolism by 31 P-MRS in 10 subjects homoplasmic for the 11778/ND4 mtDNA mutation and in also carried the two 'secondary' mutations, 4216/ND1 and 13708/ND5. 10 subjects homoplasmic for the same mutation occurring on the haplogroup J mtDNA background.
Informed consent was obtained from each patient and normal volunteer (see below), and studies were carried out with the approval of the local hospital ethics committee.
Methods

Patients 31 P-MRS
31 P-MRS was performed using a GE 1.5 T Signa system We studied 10 subjects (including four males and five affected subjects) from two unrelated families carrying only the 11778/ with a spectroscopy accessory using a surface coil provided by General Electric, and according to the quantification and ND4 mtDNA mutation (age 44 Ϯ 14 years, mean Ϯ standard deviation). Seven of them (four males, three affected males) quality assessment protocols defined by the EEC Concerted Research Project on Tissue Characterisation by MRS and were from a first family (Family 1) . This family had three affected males and 18 maternally MRI, COMAC-BME II.1.3 (EEC, 1995). Brain 31 P-MRS was performed on the occipital lobes by related unaffected individuals in the last four generations. The low penetrance in this family may be influenced partially positioning a surface coil on the occipital region after imaging the brain (Barbiroli et al., 1995) . The DRESS (depth-resolved by the presence of heteroplasmic individuals in the maternal line (Barboni et al., 1992) . The remaining three subjects surface-coil spectroscopy) localization technique (Bottomly et al., 1984) was used to prevent the neck muscles, skin and (three females, two of them affected) were from a second family (Family 2) (Family 3 in Carelli et al., 1997) . This other interposed tissues from contributing to the signal. The repetition time was 5 s. The flip angle in the selected volume family had eight affected subjects (four males and four females) and 13 maternally related, unaffected individuals in was~30°, and it was not necessary to introduce any correction for saturation effects due to repetition time. Four hundred the last two generations. All these subjects are distributed in two branches of the genealogical tree, one of which, despite free-induction decays (FIDs) were accumulated so as to have a signal-to-noise ratio of 9-12 for β-ATP. A computerized one 2-FIDs data block (10 s) was also recorded and was considered zero time, and the exercise was stopped curve-fitting program was used to quantify the individual peaks of the spectrum. By assuming a cytosolic ATP immediately afterwards. During post-exercise recovery, 10 s data blocks (2 FIDs) were recorded during the first 60 s, and concentration of 3 mM (Bottomly and Hardy, 1989), we calculated the concentrations of phosphocreatine (PCr) and 30 s data blocks were recorded thereafter for another 4 minutes. The limits of all the peaks were marked manually inorganic phosphate (Pi). In order to determine the phosphorylation potential (
on each spectrum after phasing, and areas between the limits were calculated . index of readily available free energy in the cell (Veech et al., 1979) , free cytosolic ADP concentration was calculated
The rate of mitochondrial ATP production by muscle was assessed by measuring the rate of PCr resynthesis during from the creatine kinase reaction (Degani et al., 1987) .
Muscle 31 P-MRS was performed on the right calf muscle recovery, which is entirely oxidative (Taylor et al., 1983; Arnold et al., 1984) . The rate of PCr resynthesis was by the pulse-and-acquire technique (repetition time 5 s) at rest, during in-magnet aerobic isokinetic exercise (Iotti et al., calculated from the monoexponential equation best fitting the experimental points of recovery, and was reported as 1993) and during recovery from exercise. Sixty FIDs were accumulated during rest (5 min); then exercise was begun time constants. In view of the influence of the minimum cytosolic pH, reached during recovery, on the PCr recovery and data were collected for 1 minute (12 FIDs) for each level of work. As soon as the last minute of work had been rate, all time constants were normalized to a cytosolic pH of 7.00 . completed and the corresponding 12 FIDs had been recorded, Fig. 1 31 P-MR spectra (400 FIDs) from occipital lobes of a healthy volunteer (left), a symptom-free subject carrying the 11778/ND4 mtDNA mutation (centre) and a symptom-free subject carrying the 11778/ND4 ϩ 4216/ND1 and 13708/ND5 mtDNA mutations (right). The phosphomonoester peak is located to the left of the Pi peak; the phosphodiester peak is located between the Pi and PCr peaks. The abscissa shows the chemical shift in parts per million (p.p.m.) and the ordinate the relative intensity. Intracellular pH was calculated from the chemical shift of individuals with a J haplotype background (3.35 Ϯ 0.47, P ϭ 0.3; 1.47 Ϯ 0.13, P ϭ 0.3; 47 Ϯ 13, P ϭ 0.9; Pi relative to PCr (Petroff et al., 1985) . The chemical shift was determined carefully from the centroid of the PCr peak respectively). Similarly, the only 17788/ND4 J-positive LHON patient showed brain PCr (3.06 mM) and Pi (1.40 mM) to the centroid of the Pi peak.
concentrations and phosphorylation potential (51 mM -1 ) within the range of those found in the five J-negative 11778/ ND4 LHON patients (2.87-3.87 mM, 1.37-1.65 mM and
Control data
Control subjects were healthy volunteers: there were 36 (age 34-56 mM -1 , respectively). The recovery rate of muscle phosphocreatine after exercise in asymptomatic and 37 Ϯ 17 years) for brain studies and 35 (age 38 Ϯ 16 years) for skeletal muscle studies.
symptomatic subjects with the J-associated 11778/ND4
Statistics
Data are presented as mean Ϯ standard deviation. Statistical analysis was performed with Student's t-test for unpaired data, and P Ͻ 0.05 was taken to be significant.
Results
Figure 1 shows typical spectra of occipital lobes from two symptom-free subjects, one of whom was carrying the 'primary' 11778/ND4 mtDNA mutation and the other the 11778/ND4 mutation in association with the 'secondary' 4216/ND1 and 13708/ND5 mtDNA mutations (haplogroup J), and from a sex-and age-matched control. In the two unaffected subjects carrying the LHON mutations, the phosphocreatine (PCr) peak was decreased to the same extent. Brain 31 P-MRS data are reported in Table 1 and Fig. 2 . The PCr concentration was significantly lower than in controls in both groups of 11778/ND4-positive LHON subjects, and it did not differ significantly between the two groups with the 11778/ND4 mtDNA mutation with or without haplogroup J. Similarly, the Pi concentration, compared with controls, showed a similar and significant increase in both groups of J-negative and J-associated 11778/ND4-positive subjects. Mean brain phosphorylation potential was reduced to the same extent in the J-negative and J-positive subjects with the 11778/ND4 mutation. Cytosolic pH was similar in both groups of 11778/ND4-positive subjects and did not differ from the value in controls. The concentrations of PCr and Pi in skeletal muscle at rest in the two LHON groups were similar to control values, and there was no difference between the two patient groups (data not shown). The rate of ATP production in skeletal muscle mitochondria was assessed from the post-exercise PCr recovery rate after in-magnet exercise. The time constant of post-exercise recovery of PCr in the J-negative and Jassociated LHON groups (34.5 Ϯ 11.9 and 33.7 Ϯ 10.7 s, respectively) was significantly higher than in the controls was found between the two LHON groups (P ϭ 1) (Fig. 2D) . from those found in the nine asymptomatic 11778/ND4 mutation was not significantly different from that found potential, which is a global index of the bioenergetic state of the cell. No significantly lower PCr or higher Pi in J-negative 11778/ND4 asymptomatic and symptomatic subjects, respectively (data not shown). This clearly indicates concentrations in the brain or lower phosphorylation potential was found in the presence of the two 'secondary' mtDNA that the similarity in brain and muscle energy metabolism found between J-positive and J-negative subjects is not due mutations, 4216/ND1 and 13708/ND5, indicating that these had no additive effect on oxidative phosphorylation (Table 1) . to the different number of symptomatic or asymptomatic subjects in the two groups.
The absence of any additive effect of haplogroup J on in vivo oxidative metabolism was confirmed in an extraneuronal No age-dependence was found for any 31 P-MRS variable in 11778/ND4-positive individuals (data not shown).
tissue, skeletal muscle. The rate of muscle mitochondrial ATP production was estimated from the rate of PCr resynthesis after exercise, a very sensitive index of mitochondrial function (Barbiroli et al., 1995; Lodi et al., 
Discussion
Impairment of mitochondrial energy production is an effect 1997; Chinnery et al., 2000) . The recovery rate of PCr was significantly slower in both groups of J-positive and Jcommon to the three 'primary' mtDNA mutations, 11778/ ND4, 14484/ND6 and 3460/ND1, that are pathogenically negative 11778/ND4 subjects than in controls. However, haplotype J did not further impair the rate of recovery of associated with LHON (Howell et al., 1991; Majander et al., 1991; Barbiroli et al., 1995; Lodi et al., 1997; PCr as the groups of J-negative and J-positive subjects showed virtually the same mean PCr recovery rate (Fig. 2) . 1999). Our results show that in the individuals carrying the 11778/ND4 mtDNA mutation, the 'secondary' 4216/ND1
We do not know if any of our control subjects were carrying haplogroup J, or if such haplogroup had an influence and 13708/ND5 mtDNA mutations (haplogroup J) do not further impair brain and muscle mitochondrial oxidative on in vivo mitochondrial oxidative metabolism in our healthy subjects. However, studies evaluating mitochondrial metabolism, as assessed in vivo by 31 P-MRS.
The 4216/ND1 and 13708/ND5 mtDNA base-pair respiratory function in cybrid cell lines obtained from normal subjects with and without haplogroup J did not display any substitutions have been implicated in the expression of LHON on the basis of the much more frequent occurrence of this difference in respiratory capacity between the cybrid cell lines investigated (Martinuzzi et al., 1999) . Moreover, complex I haplogroup in subjects carrying the 14484/ND6 and 11778/ ND4 mutations (Brown et al., 1997; Torroni et al., 1997) .
activity assessed in platelets from healthy subjects carrying haplogroup J did not differ from that found in healthy subjects However, haplogroup J does not alter the clinical severity of the disease when it occurs in association with a 'primary' without haplogroup J (Carelli et al., 1999) . These findings and the results of the present study suggest that the 4216/ LHON mutation (Oostra et al., 1994; Nikoskelainen et al., 1996) , and the role of haplogroup J in increasing penetrance ND1 and 13708/ND5 mtDNA base-pair substitutions do not exert any effect on mitochondrial phosphorylation, either in and the risk of disease expression for the 'primary' mutation is still controversial (Nikoskelainen et al., 1996; the presence of a normal mtDNA background or in association with the 11778/ND4 mutation, at least under the experimental 1998). Indeed, the presence of haplogroup J did not influence the expression of the 11778/ND4 mutation in the pedigree conditions described here.
In conclusion, our study does not support a synergistic we studied compared with the other two pedigrees, which had only the 11778/ND4 mutation. Cybrid cell lines carrying effect of haplogroup J and the 11778/ND4 mutation on energy metabolism deficiency in LHON. However, this finding does the 11778/ND4 mutation and haplogroup J showed lower oxygen consumption and a longer doubling time than cell not rule out a role of haplogroup J in LHON, and further studies are needed to investigate the interaction of haplogroup lines carrying the 11778/ND4 mutation alone (Vergani et al., 1995) . However, these preliminary results were obtained J with nuclear genes and environmental factors. from a limited number of clones carrying the 11778/ND4 mutation plus haplogroup J from a single patient, and more extensive investigations are in progress to confirm
